Within-group comparison of stool parameters from 0 to 8 weeks (Gp, group; VAS, visual analogue scale). Within-group comparison of stool parameters from 0 to 8 weeks (Gp, group; VAS, visual analogue scale). VSL#3 significantly decreased stool frequency, stool weight, stool mucus, diarrhoeal rate, with improvement in well-being. Mesalamine significantly decreased stool mucus and improved stool consistency and well-being. Sarika Rohatgi et al. BMJ Open Gastroenterol 2015;2:e000018 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions